Clinical Trial Update: Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of Phase 1/2 trials evaluating injections of CD4+ and CD8+ T cells targeting cytomegalovirus and adenovirus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Cytomegalovirus Infection

Drugs mentioned

• CD4+ and CD8+ T cell therapy targeting CMV and adenovirus

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cytomegalovirus Infections, Adenovirus Infections | Phase 1, Phase 2 | Status: COMPLETED